ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5
about
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthThe prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activationThe lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cellsTACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulationLIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosisDisruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry.Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transferTumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandSpecific association of glycoprotein B with lipid rafts during herpes simplex virus entryDifferential expression of LIGHT and its receptors in human placental villi and amniochorion membranesRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsActivation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motifCharacterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinaseTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingTRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungsStriking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry.The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEMFunctional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediatorThe first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC.T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.Localization of the gD-binding region of the human herpes simplex virus receptor, HveAMutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase.Recent progress in herpes simplex virus immunobiology and vaccine researchStructural and biochemical analysis of signal transduction by the TRAF family of adapter proteins.Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competitionOsteoprotegerin is a receptor for the cytotoxic ligand TRAIL.Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTStructure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease.Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway.Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
P2860
Q22003914-49511FE4-EBE7-400C-9F9C-A938DE4E01D1Q22254032-D6CC05BF-232D-4080-9746-F885FFB45DD3Q22254033-DC17D021-1E77-4659-A51C-CAE42AA07FBFQ22254448-8AB5CCF8-CFE8-4570-ABDB-BB6C4B44C2D4Q24312907-FE1E1FBC-F423-4374-8AD5-B7B575790EA7Q24537745-DD4E9104-E151-4B5C-83E9-7F6390BB5F06Q24538731-DC792CC1-68BD-4493-90CF-5F7F7CB61491Q24564377-AF367428-D17F-4246-A80C-B3C2FEFC1B43Q24642851-A91FBBC6-D99F-4C9E-86E1-C6272F75DAFAQ24653311-CC508BB8-65B0-4B07-A612-37A113C2FE4BQ24683262-77AF417C-D36E-4B21-AB29-6C4736F523DDQ24684916-A2EE7EEF-FD3C-4AED-856D-D240DBBCFEF1Q26853280-7BD95178-3149-4CB9-8C50-643F89B55BCAQ28138697-6E24FEA7-51B1-4CAD-BE60-4B4718EBBBAAQ28278061-3B0083C1-AE7E-434E-971C-1FED8F7921DDQ28513445-2EF7B387-5C5F-4FC9-ACFD-D508CA49D0ACQ28587065-0C0753CE-1C0F-4B87-9A09-D8850B1F05E4Q28587515-DBB34B00-05AF-470D-A8BF-9EF9F932988DQ28589608-1B775128-6A5F-4BC2-B016-197B3A4B8F71Q30712456-911A5922-1960-4A35-97AD-B53E0BBF03F2Q33707599-00228D8A-943C-4E95-868E-578B8E93C8B6Q33782305-33C2CB32-9A11-4AF3-814C-CE2462A02D3DQ33782593-683C7BD8-4FAF-417B-915E-40CF7E23DB50Q33783757-D8CCA6F3-2140-4A9D-A4B3-5EE322078E5EQ33819243-D069E004-DEDD-46F0-B391-1815D7FD6DFAQ33832366-650FAE8E-19FD-47E8-8B2E-C382E02F5E16Q33834657-DCB23E8C-5D22-4E48-92A8-63328EBD1C06Q33958468-ADBAAAC3-5920-4748-9AA3-193F890A79D8Q33963713-E4A518F0-7448-4778-81FD-321AFADCB764Q34170959-BA5D65F0-8A33-4D0A-A37A-CB3C0FFE54C4Q34250209-8248DBB8-385D-4515-A6F9-020DD6EED240Q34295959-6635AFF1-9689-43FB-BAD7-F2D5F54995F3Q34469691-939D0221-3164-44B6-BEBE-868F75EF77CFQ34621654-DAF57AAD-8139-4143-96F3-9A8119F81734Q34831085-F7F10F1B-A00B-4D73-B582-FCEB92F6B74AQ35105049-7A2D4531-3CEE-45D5-8278-08263DCC0F8DQ35149611-BB9003C0-F199-4EC4-B6E9-D5338FF14033Q35924786-DA629850-C791-4CFE-A9F8-933DFD51B541Q36004058-A9A989BA-5368-478A-B580-8DE82D8D694BQ36053977-408A3074-A0EC-462C-9029-913933A95787
P2860
ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@ast
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en-gb
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@nl
type
label
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@ast
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en-gb
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@nl
prefLabel
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@ast
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en-gb
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@nl
P2093
P2860
P356
P1476
ATAR, a novel tumor necrosis f ...... ignals through TRAF2 and TRAF5
@en
P2093
P2860
P304
P356
10.1074/JBC.272.21.13471
P407
P577
1997-05-23T00:00:00Z